Vmbook Online ordering

Anthera Pharmaceuticals Inc

Anthera Pharmaceuticals, Inc. was a biopharmaceutical company that focused on developing and commercializing products to treat diseases with significant unmet medical needs. The company's lead product candidate was blisibimod, a novel investigational drug that targeted B-cells and spleen tyrosine kinase (SYK) for the treatment of B-cell diseases, including autoimmune diseases and B-cell malignancies.

Anthera Pharmaceuticals, Inc was incorporated in 2004 and was headquartered in Hayward, California, USA. The company's common stock traded on the NASDAQ Capital Market under the symbol "ANTH".

Unfortunately, Anthera Pharmaceuticals, Inc. filed for bankruptcy and discontinued its operations. Therefore, it is no longer listed on the NASDAQ stock exchange.